Molecular & Cellular Physiology

2019 in Review: Top 10 Kidney News Articles

2019 brought another successful year of nephrology coverage by ASN Kidney News and Kidney News Online. The two publications covered a broad spectrum of topics within nephrology and continued their strong record of informing the nephrology community.

Kidney Week On-Demand 2019 Now Available

Kidney Week On-Demand 2019 is now available! The site provides recordings and presentation slides from the 2019 ASN Annual Meeting in Washington, DC.

If you were unable to attend or missed a session, now is your chance to access approximately 220 hours of recorded presentations with Kidney Week On-Demand!

Interview with Dr. Michael Allon, editor-in-chief of Kidney360, on new ideas for the journal

allon-michael2_1.jpgKidney News Online (KNO) recently spoke with Michael Allon, MD, the inaugural Editor-in-Chief for the newest journal from the American Society of Nephrology, Kidney360. As the open access, online only journal began accepting manuscripts on October 1st, KNO wanted to learn more about the ideas behind the new journal.

 

First US cell-therapy trial for kidney transplant patients launched at University of Wisconsin Health

“The UW Program for Advanced Cell Therapy (PACT) will use the personalized cell therapy treatment to study its effects on a viral infection faced by around 30-40% of kidney and/or pancreas transplant recipients.

Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors

Announced July 25, Dr. Reshma Kewalramani will be promoted to president and CEO of Vertex Pharmaceuticals. She is currently the chief medical officer for the company and was previously a practicing nephrologist who earned her medical doctorate at Boston University and trained at Bigham & Women’s Hospital.

Dr. Kewalramani will be the first woman to run a large biotechnology firm. Vortex’s share price “rose 360% and its sales doubled to $3 billion annually” under the previous CEO, largely due the company’s pharmaceuticals used to treat cystic fibrosis.

Q&As with KidneyCure Grant Recipients 2019

The following articles are brief Q&A sessions with KidneyCure (ASN Foundation) grant recipients. The sessions explore what research the individual is undertaking with the grant funds, their hopes for the research, career goals, and advice for others interested in applying for these grant funds.

In Case You Missed It: Top 20 Ways ASN is Increasing Interest in Nephrology Careers

March is National Kidney Month and to celebrate, Kidney News Online and In The Loop are highlighting the top 20 ways the American Society of Nephrology (ASN) and the ASN Foundation for Kidney Research are increasing interest in nephrology careers.

Together, ASN and the ASN Foundation for Kidney Research:

Marcello Tonelli, MD, SM, MSc speaks about the complexities of treating nephrology patients in recent study

tonelli.jpgA recent study was published online in the Journal of the American Medical Association (JAMA) entitled “Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System” on November 30, 2018.

Please access the abstract and full report on the JAMA website.

Community-Minded: A Review of the ASN Communities for 2018

Three years ago, the ASN developed and released ASN Communities with the objective of creating an international venue to network, collaborate and discuss important issues in a members-only environment. Since the launch:

Pages